What is HEM stock price?

HEM (Hemostemix Inc) is currently trading at $0.06 on the Toronto Stock Exchange (TSX).

Stocks/TSX-V/HEM

Hemostemix Inc (HEM : TSX-V)

Common Stock

$0.06

CAD

-0.00 (-8.33%)

Last updated: 2026-10-19

Follow HEM

HEM

Hemostemix Inc

Source:

WealthAwesome

↓ $0.02 (-26.67%)

30 day period

Performance

1 Day

-8.33%

1 Week

-26.67%

1 Month

-21.43%

YTD

-38.89%

Key Statistics

Market Cap

$12.69M

52W High

$0.11

52W Low

$0.04

P/E Ratio

50 Day MA

$0.07

200 Day MA

$0.07

Beta

0.73

Dividend Yield

Technical Indicators

Price vs 50-Day SMA

↓Below 50 SMA

Price vs 200-Day SMA

↓Below 200 SMA

Recent Price History

Date	Open	High	Low	Close	Adj Close	Volume
10/19/2026	$0.06	$0.06	$0.06	$0.06	$0.06	2,074
10/16/2026	$0.06	$0.06	$0.06	$0.06	$0.06	15,000
10/15/2026	$0.06	$0.07	$0.06	$0.06	$0.06	37,150
10/14/2026	$0.06	$0.06	$0.06	$0.06	$0.06	11,000
10/13/2026	$0.06	$0.06	$0.06	$0.06	$0.06	251,949
10/8/2026	$0.07	$0.07	$0.07	$0.07	$0.07	11,777
10/7/2026	$0.07	$0.07	$0.07	$0.07	$0.07	7,000
10/5/2026	$0.06	$0.07	$0.06	$0.07	$0.07	21,650
10/2/2026	$0.06	$0.06	$0.06	$0.06	$0.06	0
10/1/2026	$0.06	$0.06	$0.06	$0.06	$0.06	5,000

Analyst Price Targets

Based on analyst covering HEM · as of Sep 17, 2026

📈

Wall Street analysts forecast HEM stock price to rise 1645.5% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$0.96

+1645.5% Upside

Current Price

C$0.06

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on HEM's historical volatility

HistoricalForecast68%95%

30-Day Vol

105.9%

Annualized

90-Day Vol

118.9%

Annualized

Trend (90d)

+0.0%

Annualized drift

90d Mean

C$0.06

Expected price

Horizon	Expected	68% Range (1σ)	95% Range (2σ)
30 trading days	C$0.06	C$0.04 – C$0.08	C$0.03 – C$0.11
60 trading days	C$0.06	C$0.03 – C$0.09	C$0.02 – C$0.15
90 trading days	C$0.06	C$0.03 – C$0.10	C$0.02 – C$0.19

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Hemostemix Inc

Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which completed Phase II clinical trial for the treatment of peripheral arterial disease, chronic limb threatening ischemia, cardiovascular ischemia and angina, and vascular dementia. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.

Financials

Revenue (TTM): $0
EBITDA: $-5.06M
Profit Margin: 0.00%
ROE (TTM): 0.00%
EPS (Diluted): -0.03
Book Value: -0.03

Classification

Sector: Health Care
Industry: Biotechnology
Group: Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Explore More

Stock Screener TSX Stocks TSXV Stocks

Common Questions About HEM

Market movers

Recent TSX-V movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →

Ticker	Name	Price	1D
TNX	TenX Protocols Inc.	$51.36	+42700.00%
IMPT	Impact Development Group Inc.	$0.01	+200.00%
DRAX-P	Draxos Capital Corp.	$0.17	+142.86%
DELX	DelphX Capital Markets Inc	$0.01	+100.00%
RUN-H	Running Fox Resource Corp	$0.01	+100.00%
RAC-P	Riverwalk Acquisition Corp.	$0.03	+50.00%
AUTO	Agereh Technologies Inc	$0.04	+40.00%
GGM	Granada Gold Mine Inc	$0.04	+33.33%